Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Consultas o comentarios: productividad@anid.cl
| Firmas del autor | |
| Nombre | AVALOS, IGNACIO |
| Género | Hombre |
| Área Principal WOS | Immunology; Oncology; |
| Afiliación Principal | Universidad De Chile |
ORCID
|
0000-0001-8838-654X |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
Periodo registrado: 2008 - 2024
| Autor | Género | # Pub |
|---|---|---|
| SALAZAR ONFRAY, F. | Hombre | 1 |
| BECKER, M. I. | - | 1 |
| ROJAS, D. | Mujer | 1 |
| BARRIA, O. | Hombre | 1 |
| NAVARRETE, MARIELA | Mujer | 4 |
| GUERRERO, ISRAEL | Hombre | 1 |
| GONZALEZ, FERNANDO | Hombre | 2 |
| VILLAR, JAVIERA | Mujer | 1 |
| LOPEZ-NITSCHE, MERCEDES NATALIA | Mujer | 6 |
| FLUXA, PAULA | Mujer | 1 |
| MENDOZA-FUENTES, CAROLINA | Mujer | 1 |
| SABANEGH, S. | - | 1 |
| GALLEGOS-MENDEZ, IVAN MARCELO | Hombre | 1 |
| SALAZAR-LIZAMA, FABIAN ALBERTO | Hombre | 1 |
| TITTARELLI, ANDRES | Hombre | 5 |
| GLEISNER-MUNOZ, MARIA ALEJANDRA | Mujer | 7 |
| DEL CAMPO-ZALDIVAR, MIGUEL | Hombre | 1 |
| GONZALEZ-BERGAS, FERMIN EDUARDO | Hombre | 2 |
| ORTIZ, C. | Mujer | 1 |
| MICHEA, LUIS | Hombre | 1 |
| BECKER-CONTRERAS, MARIA INES | Mujer | 2 |
| MANUBENS, AUGUSTO | Hombre | 1 |
| SALAZAR-ONFRAY, FLAVIO ANDRES | Hombre | 6 |
| ROJAS-SEPULVEDA, DANIEL | Hombre | 1 |
| BUTTE, JEAN M. | Hombre | 1 |
| SALAZAR, MICHELLE L. | Mujer | 1 |
| JIMENEZ, JOSE M. | Hombre | 1 |
| TEMPIO, FABIAN | Hombre | 5 |
| ARAYA, JUAN PABLO | Hombre | 1 |
| PEREDA, CRISTIAN | Hombre | 5 |
| ROA, JUAN CARLOS | Hombre | 1 |
| Año | Firma | Institución (Incites asoc.) | H Index | Average Percentile | Impact Citation | Impact Relative World | Impact Journal Normalized Citation | Impact Category Normalized Citation | Percentage Cited | Percentage Top 1 | Percentage Top 10 | Percentage Journal Q1 | Percentage Journal Q2 | Percentage Journal Q3 | Percentage Journal Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | Avalos, I. | Universidad de Chile | 1.0 | 56.2 | 13.0 | 1.5 | 0.6 | 0.8 | 50.0 | 0.0 | 0.0 | 50.0 | 50.0 | 0.0 | 0.0 |
| 2019 | Avalos, Ignacio | Universidad de Chile | 1.0 | 70.9 | 1.0 | 0.1 | 0.3 | 0.3 | 100.0 | 0.0 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 |
| Palabra Clave | #Pub |
|---|---|
| melanoma | 3 |
| immunotherapy | 2 |
| dendritic cells | 2 |
| gm-csf | 2 |
| metastatic melanoma | 1 |
| model | 1 |
| metastasis | 1 |
| macrophage mannose receptor | 1 |
| keyhole limpet hemocyanin | 1 |
| ipilimumab | 1 |
| investigational | 1 |
| intercellular communication | 1 |
| innate | 1 |
| infiltrating immune cells | 1 |
| increases | 1 |
| in-vivo | 1 |
| immunomodulators | 1 |
| responses | 1 |
| vivo tumor-growth | 1 |
| vaccines | 1 |
| vaccine | 1 |
| tumour growth | 1 |
| tumor lysates | 1 |
| therapies | 1 |
| survival | 1 |
| sign | 1 |
| immunity | 1 |
| regulatory t | 1 |
| prostate-cancer | 1 |
| prolonged survival | 1 |
| phenotype | 1 |
| phase-i | 1 |
| n-glycans | 1 |
| mr | 1 |
| dc-sign | 1 |
| alarmins | 1 |
| antigen uptake | 1 |
| apoptosis | 1 |
| binding | 1 |
| blockade | 1 |
| breast-cancer | 1 |
| breast-cancer cells | 1 |
| cancer | 1 |
| carcinoma | 1 |
| cell-death | 1 |
| citim 2017 | 1 |
| clinical-significance | 1 |
| colony-stimulating factor | 1 |
| concholepas hemocyanin | 1 |
| cx43 | 1 |
| immunogenicity | 1 |
| dc‐ | 1 |
| death | 1 |
| efficacy | 1 |
| expression | 1 |
| gallbladder cancer | 1 |
| gap junction | 1 |
| gap junctional communication | 1 |
| genes | 1 |
| growth | 1 |
| hemocyanin | 1 |
| hemocyanins | 1 |
| human dendritic cells | 1 |
| identification | 1 |
| active | 1 |
Descargar
Descarga los datos de esta página (formato JSON).
Descargar
Descarga los datos de esta página como un archivo Excel.
